Agios Pharm
AGIO
$33.29-0.09%
Delayed · as of Aug 31, 2026, 10:20 AM ET
Mkt cap
$1.68B
EV/Sales
29.5
P/E ratio
N/A
FY2025 Revenue
$54.03M
EPS (TTM)
$-7.01
Gross Margin (FY2025)
88.26%
Profit Margin (FY2025)
-764.01%
Beta
0.59
Div yield
N/A
Sector
Healthcare
Agios Pharm (AGIO) is a biotechnology company listed on US.
Latest reported AGIO revenue for 2025-12-31 was $54.0M. Net income was -$412.8M. Revenue was up 48.0% from 2024-12-31 to 2025-12-31. AGIO currently screens at market cap $1.68B.
Use this AGIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AGIO income, balance, and cash tables.
Agios Pharm (AGIO) is a biotechnology company in the Healthcare sector.
Latest cached Agios Pharm (AGIO) revenue for Dec 31, 2025 was $54.0M. Net income was -$412.8M. Statements: https://lician.com/financials/agio
Agios Pharm (AGIO) market capitalization is $1.68B on the latest cached snapshot.
Agios Pharm (AGIO) cached previous close $33.32; day range $32.93 – $33.51; volume 84,168. Session quote: https://lician.com/quote/agio
Agios Pharm (AGIO) latest cached earnings event is "AGIO earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AGIO filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/agio